Hemostasis and Tissue Sealing Agents Market, By Product Type, By Application, By End User, and By Region

Description

The global hemostasis and tissue sealing agents market size is valued at US$ 3.39 Billion in 2023 and is expected to reach US$ 4.95 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.39 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.60%	2030 Value Projection:	US$ 4.95 Bn

Figure 1. Global Hemostasis And Tissue Sealing Agents Market Share (%), By Region, 2023

Hemostasis and Tissue Sealing Agents Market - IMG1

Hemostasis and tissue sealing agents play a vital role in surgical procedures by enabling surgeons to control bleeding and seal tissues. They work by forming a protective layer over incisions and wounds to accelerate the body's natural clotting process. Some commonly used hemostasis and tissue sealing products include sealants, glues, fibrin patches, collagen-based solutions, and absorbable gels. The global hemostasis and tissue sealing agents market has been growing in response to the rising need for more effective hemorrhage management solutions across various surgical specialties like cardiovascular, orthopedic, neurovascular, and general surgeries.

Market Dynamics:

The key drivers fueling the hemostasis and tissue sealing agents market include rapid growth in surgical procedures globally, increasing preference for minimally invasive surgeries, rising healthcare spending in emerging nations, and technological advancements leading to improved product portfolios. However, factors such as product recalls owing to safety concerns, stringent regulatory norms, and price pressures from large generic manufacturers pose significant challenges. On the positive side, ongoing research and development towards developing next-gen hemostats and sealants with superior efficacy is opening new avenues for market players. Growing applications of tissue adhesives in traumatic injury repair also present attractive opportunities for growth of hemostasis and tissue sealing agents market.

Key Features of the Study:

This report provides an in-depth analysis of the global hemostasis and tissue sealing agents market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hemostasis and tissue sealing agents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Ethicon (a subsidiary of Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now part of Medtronic), Integra LifeSciences, Pfizer, BD, Teleflex and Arch Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hemostasis and tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis and tissue sealing agents market

Detailed Segmentation:

By Product Type:
- Topical Hemostats & Adhesives
- Tissue Sealing Agents
By Application:
- Cardiovascular Surgery
- Orthopedic Surgery
- General Surgery
- Neurosurgery
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Ethicon (a subsidiary of Johnson & Johnson)
- Baxter International
- CryoLife
- Braun Melsungen AG
- Covidien (now part of Medtronic)
- Integra LifeSciences
- Pfizer
- BD
- Teleflex
- Arch Therapeutics

Product Code: CMI1567

Table of Contents:

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Hemostasis and Tissue Sealing Agents Market , By Product Type
- Global Hemostasis and Tissue Sealing Agents Market , By Application
- Global Hemostasis and Tissue Sealing Agents Market , By End User
- Global Hemostasis and Tissue Sealing Agents Market , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Hemostasis and Tissue Sealing Agents Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Hemostasis and Tissue Sealing Agents Market, By Product Type, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Topical Hemostats & Adhesives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Tissue Sealing Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Hemostasis and Tissue Sealing Agents Market, By Application, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Hemostasis and Tissue Sealing Agents Market, By End User, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Hemostasis and Tissue Sealing Agents Market, By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Ethicon (a subsidiary of Johnson & Johnson)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CryoLife
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B.Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Covidien (now part of Medtronic)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BD
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teleflex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arch Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

10. Section

Research Methodology
About us